During the past decade, Western Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 25 clinical trials were completed, i.e. on average, 69.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Western Hospital" #1 sponsor was "Gilead Sciences" with 9 trials, followed by "Celgene" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Galapagos NV" with 5 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Western Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Monash University" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Western Hospital" are "Crohn's Disease" (6 trials), "Ulcerative Colitis" (6 trials), "Chronic Hepatitis C" (5 trials), "Eosinophilic Esophagitis" (3 trials) and "Hepatitis C, Chronic" (3 trials). Many other conditions were trialed in "Western Hospital" in a lesser frequency.

Most popular intervention types in "Western Hospital" are "Drug" (72 trials), "Other" (11 trials), "Biological" (6 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Guselkumab" (5 trials), "Filgotinib" (4 trials), "Capecitabine" (3 trials) and "Etrasimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Western Hospital" are 82 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Western Hospital". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Western Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Western Hospital, 3 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 5 trials that are defined as “Not Applicable".